Related Experiment Video
Updated: Jan 14, 2026

High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids
Published on: June 14, 2021
Realizing Equitable Precision Oncology via Remote Participation: Japan's First Fully Decentralized Trial (WJOG15221M)
Hiroya Taniguchi1, Toshiki Masuishi1, Tomoki Sakakida1,2
1Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Abstract:
WJOG15221M is Japan's first fully remote, investigator-initiated oncology trial, successfully enrolling 28 patients-36% remotely-by integrating trial access into the national CGP program and leveraging existing healthcare infrastructure without new digital tools. Targeting rare ALK fusion-positive tumors, the trial demonstrated that decentralized models can improve equity, efficiency, and continuity of care, offering a scalable path for future precision oncology trials.
More Related Videos
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
05:39Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
Published on: April 5, 2024
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Treatment Resistant Cancers
Clinical Trials: Overview
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...